Oncology News

More than 2 billion children and adults globally were affected by excess weight in 2015, and the percentage of people dying from health conditions stemming from being overweight or obese is rising, according to findings published in The New England Journal of Medicine.

Surefire Medical released results of a retrospective study of bridge-to-transplant patients with hepatocellular carcinoma treated with transarterial chemoembolization, or DEB-TACE, that showed a higher complete response rate using the Surefire Infusion System compared with standard endhole microcatheter, according to a press release.

CHICAGO — Results of a phase 3 trial showed that Lenvima was non-inferior to Nexavar in median overall survival for patients with unresectable hepatocellular carcinoma, according to a presentation at the ASCO Annual Meeting.

Exposure to air pollution with particulate matter over 2.5 m in diameter, or PM2.5, after diagnosis of hepatocellular carcinoma had adverse effects in patients and may shorten overall survival, according to a retrospective study.

New data revealed an association between postmenopausal estrogen use and a reduced risk for hepatocellular carcinoma and increased overall survival time in women with HCC.

Viral eradication with direct-acting antivirals does not appear associated with an increased risk for liver transplant waitlist drop-out due to hepatocellular carcinoma progression in patients with hepatitis C, according to a recently published study.

Among the presentations at this year’s Digestive Disease Week, physician experts and clinical professionals discussed new data on liver disease diagnosis and treatment, including topics such as gut microbiota, liver transplantation, fatty liver disease and viral hepatitis, as well as advances in the world of telemedicine and unique approaches in patient management.

The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer.

Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting antiviral therapy compared with patients without HCC, according to results of a retrospective study.

Hepatocellular carcinoma was linked to patients with hepatitis B in South America, particularly those younger than 50 years, according to results of a retrospective, multi-center study.